Skip to main content
. Author manuscript; available in PMC: 2009 Sep 30.
Published in final edited form as: Circulation. 2008 Sep 15;118(14):1419–1424. doi: 10.1161/CIRCULATIONAHA.108.771303

Table 3.

Prevalence of PFO among subjects with migraine selected from the literature including data from the current NOMAS study

STUDY PFO Method Migraine With Aura Migraine Without Aura NO Migraine
Del Sette et al. (10) Cerebrovas Dis. 1998 TCD 18/44 (41%) NA 8/50 (16%)
Anzola et al. (9) Neurology. 1999 TCD 54/113 (48%) 12/53 (23%) 5/25 (20%)
Schwerzmann et al. (8) Neurology. 2005 TEE 44/93 (47%) NA 16/93 (17%)
Dalla Volta et al. (31) J Headache Pain. 2005 TCD 161/260 (62%) 12/74 (16%) NA
Carod-Artal FJ et al. (33) Cephalalgia. 2006 TCD 25/48 (51%) 32/93 (34%) NA
Domitrz et al. (11) Headache. 2007 TCD 33/61 (54%) 15/60 (25%) 16/65 (25%)

NOMAS TTE 26/140 (19%) 4/38 (11%) 138/923 (15%)
HHS Vulnerability Disclosure